Skip to main content

Interim Analyses

  • Chapter
  • First Online:
  • 6185 Accesses

Abstract

Clinical trials tend to have a long duration, because mostly patients are enrolled one by one, and their responses to treatment are observed sequentially. For the organizers this part of the trial is an exciting phase because after all the hard work involved in planning and getting the trial started, finally concrete data will become available. Immediately, there is the possibility to look at the data in order to check that the trial protocol is pursued appropriately by the investigators and to look at any difficulties, e.g., those with patient and/or doctor compliance, and to see whether there is any need for protocol alterations (Pocock 1988a). “Looking at the data” for such purposes should, however, be done carefully. In this chapter we will discuss questions such as:

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Armitage P (1975) Sequential medical trials. Blackwell, Oxford

    Google Scholar 

  • Demets DL, Ware JH (1980) Group sequential methods in clinical trials with a one-sided hypothesis. Biometrika 67:651–660

    Article  Google Scholar 

  • Department of Health and Human Services, Food and Drug Administration (1998) International conference on harmonisation; guidance on statistical principles for clinical trials availability. Fed Regist 63(179):49583–49598

    Google Scholar 

  • Food and Drug Administration (1996) Guideline for industry. Structure and content of clinical study reports. FDA. At internet website WWW.DFA.GOV/CDER/REGGUIDE.HTM/GUIDANCEDOCUMENTS

  • Pocock SJ (1977) Group sequential methods in the design and analysis of clinical trials. Biometrika 64:191–199

    Article  Google Scholar 

  • Pocock SJ (1988a) Clinical trials. A practical approach. Wiley, New York, p 62

    Google Scholar 

  • Pocock SJ (1988b) Clinical trials. A practical approach. Wiley, New York, p 147

    Google Scholar 

  • Pocock SJ (1988c) Clinical trials. A practical approach. Wiley, New York, p 153

    Google Scholar 

  • Pocock SJ (1988d) Clinical trials. A practical approach. Wiley, New York, p 149

    Google Scholar 

  • Wald A (1947) Sequential analysis. Wiley, New York

    Google Scholar 

  • Whitehead J (1983) The design and analysis of sequential clinical trials. Ellis Horwood publishers, Chichester

    Google Scholar 

  • Whitehead J (1998) Planning and evaluating sequential trials (PEST, version 3). University of Reading, Reading. www.reading.ac.uk/mps/pest/pest.html

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Cleophas, T.J., Zwinderman, A.H. (2012). Interim Analyses. In: Statistics Applied to Clinical Studies. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2863-9_7

Download citation

Publish with us

Policies and ethics